This inventor holds 1 USPTO granted patent. Top assignee: Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sebastien Tremblay: Innovator in Gallium-68 Production
Introduction
Sebastien Tremblay is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of radiopharmaceuticals, particularly in the production and purification of gallium-68. His innovative work has implications for medical imaging and treatment.
Latest Patents
Sebastien Tremblay holds a patent for "Processes and systems for producing and/or purifying gallium-68." This patent describes processes that utilize two cation-exchange chromatography columns to effectively separate gallium from zinc and other impurities. The method achieves a high overall yield of gallium while maintaining a high effective molar activity. Additionally, the process is designed to be implemented in a timeframe compatible with the short half-life of gallium-68. In some embodiments, the process can be automated, enhancing its efficiency and practicality.
Career Highlights
Tremblay is associated with the Société de Commercialisation des Produits de la Recherche Appliquée (Socpra Sciences Santé et Humaines S.E.C.). His work at this company has allowed him to focus on advancing technologies related to radiopharmaceuticals, contributing to the healthcare sector.
Collaborations
Sebastien has collaborated with several professionals in his field, including Brigitte Guerin and Aiman H Alnahwi. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Sebastien Tremblay's contributions to the production and purification of gallium-68 highlight his role as an important inventor in the field of radiopharmaceuticals. His innovative processes not only enhance the efficiency of gallium production but also have significant implications for medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile